Related Experiment Video
Updated: Feb 26, 2026

The Cell-based L-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins
Published on: December 13, 2013
Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway
Yukie Takahashi1, Chizu Tanikawa1, Takafumi Miyamoto1
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Abstract:
p53, one of the most frequently mutated genes in colon cancer, suppresses cancer development through transactivation of its targets. Herein, we conducted a comprehensive analysis of the p53 downstream pathway in colorectal cancer by using multi-omics analysis. Mass spectrometric analysis of HCT116 p53+/+ and HCT116 p53-/- cells treated with adriamycin identified 124 proteins increased by DNA damage in a p53-dependent manner. Further screening using a cDNA microarray and the TCGA database revealed MICALL1 as a novel p53 target, and we identified functional p53 binding motifs located approximately 3000 base pairs upstream of the MICALL1 gene. MICALL1 expression was significantly decreased in colorectal cancer tissues with p53 mutation compared with those without p53 mutation. In response to DNA damage, MICALL1 co-localized with RAB8A and CD2AP at tubular recycling endosomes, whereas these proteins hardly localized at tubular recycling endosomes when p53 or MICALL1 expression was inhibited by siRNA. Our findings show that p53 regulates tubular recycling endosome biogenesis via transcriptional regulation of MICALL1, whose expression is frequently suppressed in colorectal cancer tissues.
Insights
The tumor suppressor p53 regulates colorectal cancer cell development by controlling MICALL1 expression. This study reveals p53
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 gene is frequently mutated in colorectal cancer, impacting tumor suppression.
- Understanding the p53 downstream pathway is crucial for colorectal cancer treatment.
Purpose of the Study:
- To comprehensively analyze the p53 downstream pathway in colorectal cancer using multi-omics data.
- To identify novel p53 targets and their role in colorectal cancer development.
Main Methods:
- Multi-omics analysis including mass spectrometry and TCGA database.
- Screening of HCT116 p53+/+ and HCT116 p53-/- cells treated with adriamycin.
- Analysis of gene expression and protein localization via siRNA inhibition.
Main Results:
- Identified 124 proteins upregulated by DNA damage in a p53-dependent manner.
- Discovered MICALL1 as a novel p53 target with functional binding sites.
- Found decreased MICALL1 expression in p53-mutated colorectal cancer tissues.
- Demonstrated p53-dependent co-localization of MICALL1, RAB8A, and CD2AP at tubular recycling endosomes.
Conclusions:
- p53 transcriptionally regulates MICALL1, impacting tubular recycling endosome biogenesis.
- MICALL1 expression is frequently suppressed in colorectal cancer, particularly in tumors with p53 mutations.
- These findings highlight a novel p53-MICALL1 axis in colorectal cancer pathogenesis.
Related Concept Videos
Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
Negative Regulator Molecules
The Early Endosome: Endocytosis of Transferrin
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

